Edwige Gros

Title: Edwige Gros: Innovator in Antibody Therapeutics

Introduction

Edwige Gros is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of antibody therapeutics. With a total of 10 patents to his name, Gros has made remarkable advancements in the development of innovative treatments for various diseases.

Latest Patents

One of Gros's latest patents involves antigen binding proteins that bind PD-1. This patent discloses compositions and methods related to anti-PD-1 antibodies, including fully human antibodies that bind PD-1, as well as PD-1-binding fragments and derivatives. The patent also covers nucleic acids encoding these antibodies and methods for treating or diagnosing subjects with PD-1 related disorders, including inflammatory disorders and cancers. Another significant patent focuses on methods for blocking the interaction between notch-1 and delta-like 4 (DLL-4) by administering a DLL-4 antibody. This patent details fully human antibodies that bind DLL-4 and includes methods for treating or diagnosing subjects with DLL-4 related disorders.

Career Highlights

Edwige Gros is currently employed at Sorrento Therapeutics, Inc., where he continues to push the boundaries of antibody research and development. His work has been instrumental in advancing therapeutic options for patients suffering from various conditions.

Collaborations

Gros collaborates with notable colleagues, including Heyue Zhou and Barbara Anne Swanson, who contribute to the innovative research environment at Sorrento Therapeutics.

Conclusion

Edwige Gros's work in the field of antibody therapeutics exemplifies the impact of innovation in medicine. His patents and ongoing research are paving the way for new treatments that could significantly improve patient outcomes.